Panitumumab enhances second-line FOLFIRI in phase III: Commentary Journal Article
| Author: | Lichtman, S. M. |
| Article Title: | Panitumumab enhances second-line FOLFIRI in phase III: Commentary |
| Keywords: | controlled study; treatment outcome; gene mutation; major clinical study; overall survival; clinical trial; fluorouracil; cancer combination chemotherapy; diarrhea; drug efficacy; skin toxicity; note; drug targeting; colorectal cancer; cancer immunotherapy; metastasis; progression free survival; controlled clinical trial; randomized controlled trial; epidermal growth factor receptor; clinical protocol; food and drug administration; irinotecan; panitumumab; health status; add on therapy; folinic acid; outcomes research; phase 3 clinical trial; oncogene k ras; drug indication |
| Journal Title: | The Oncology Report |
| ISSN: | 1548-5323 |
| Publisher: | International Medical News Group LLC |
| Date Published: | 2010-03-01 |
| Start Page: | 15 |
| End Page: | 15 |
| Language: | English |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | --- - "Export Date: 20 April 2011" - "Source: Scopus" |
MSK Authors
-
228Lichtman